What Celsius Bears Saw Before A 54% Drop

If you had chosen Celsius on 28 October 2025 because health-focused drinks sounded safer than most growth stories, the next twelve months looked very different to that comfort narrative. For Celsius shareholders, the loss over the past year was 54.4%, including dividends. Recent lawsuits, earnings pressure, and management upheaval now grab headlines. What early assumption about regulation, margins, or brand risk could you have stress tested before any of that news arrived?

If the move has made Celsius harder to judge, start where the gap is still open and scan 26 high quality undervalued stocks.

The Argument Celsius Investors Were Balancing

The shares cost US$61.9 at the start of the period, and investors in Celsius faced two sharply different stories about what that price already assumed.

The bullish case leaned on expanding health trends, with a Fair Value of US$66.28, a notional price based on revenue growing 30.1% a year and profit margins reaching 14.5% within three years.

The cautious view worked off a Fair Value of US$33.5 and focused on tightening beverage regulation and supply chain strain putting lasting pressure on margins.

What The Facts Did To The Celsius Thesis

Celsius went into the period with a health-driven growth story, yet the headline developments cut the other way. Q2 2026 revenue reached US$817.9m versus US$739.3m a year earlier, while net income fell to US$36.4m from US$85.7m and net margin declined from 11.6% to 4.5%. Class action filings over Alani Nu health risks and an earnings miss with margin pressure supported the cautious case.

The useful takeaway is where you focus your checks. When a bullish pitch leans on future profitability, track reported net margin, not just sales and distribution wins, and pressure test how much regulatory and product risk could pull that margin away from the forecast.

What Celsius Buyers Today Are Really Betting On

Celsius now trades at US$27.98. The selected Narrative places its Fair Value above that level, arguing the stock price reflects distribution noise more than a broken business.

The story hinges on Pepsi partnerships, Alani Nu and Rockstar integrations, and retail data that point to consumer demand rather than reported shipment swings. Any buyer today must believe that what looked like a collapse was an inventory and accounting issue, not a signal that the core brands have lost relevance.

"In 2010, Celsius Holdings (CELH) was generating roughly US$5 million in annual revenue, a forgotten energy drink with niche distribution in Scandinavian gyms and a handful of US health food stores. By the end of 2025, the company had crossed US$2 billion in trailing twelve-month revenue and acquired two major energy drink brands."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Where A Celsius Check Might Lead

Celsius asks you to decide how much brand risk feels acceptable today. One step away, a quieter beverage story waits for inspection and comparison.

This other business leans on long shelf lives and familiar packaged staples. It has been spending money to refresh labels and recipes instead of constant reinvention.

Management there has talked more about protecting cash payouts and steadily reducing debt obligations than about headline-ready restructurings or dramatic portfolio shifts.

If Celsius seems like a wager on what comes next, this peer looks more like a patient hold. The open question is which version of durability you want to examine first.

That argument has a Narrative and a number behind it. → See the company one Narrative values 47% above its price

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com